Reduced antibody response to streptavidin through site-directed mutagenesis
about
Structure-based design and synthesis of a bivalent iminobiotin analog showing strong affinity toward a low immunogenic streptavidin mutantStructure-based design of a streptavidin mutant specific for an artificial biotin analoguePEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinityUltrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound AgentBiochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).Non-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidin.Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging.Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cellsAddressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Recent developments with B-cell epitope identification for predictive studies.Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics.Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers.Assessment of Molecular Acoustic Angiography for Combined Microvascular and Molecular Imaging in Preclinical Tumor Models.Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles.Prescreening of Nicotine Hapten Linkers in Vitro To Select Hapten-Conjugate Vaccine Candidates for Pharmacokinetic Evaluation in Vivo.Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.Efficient delivery of p53 and cytochrome c by supramolecular assembly of a dendritic multi-domain delivery system.Combinatorial Therapies After Spinal Cord Injury: How Can Biomaterials Help?Transtactin: a universal transmembrane delivery system for Strep-tag II-fused cargos.Aptamer mediated siRNA delivery.Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin.Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment.Novel avidin-like protein from a root nodule symbiotic bacterium, Bradyrhizobium japonicum.Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results.
P2860
Q27697299-0BE0D369-7EAE-4FB9-9C38-40DEFB1C72FCQ27697883-7FDB2933-A529-49E0-9B3D-CEAF52342879Q28741459-050A8DA9-D25D-4965-9D8D-4A0CFA399F6AQ30375870-166C15DF-D405-45FF-B39E-89E35C4A198EQ30384834-5E067CD7-3D25-4281-90B0-FEBC2464CB77Q30474689-9C5CEA5D-A3A4-4879-A901-6E78DDEE4078Q34086269-96B43427-EFA8-4D6C-91B0-5C25415A9970Q34171483-3261470C-A8AB-45AA-AB07-5B32EA015086Q35144394-BF2C9B3D-8ED1-4263-ACF1-954E97E5B753Q36395999-E04F44AB-8735-405E-8F0A-EA247B6B9A80Q37311033-F2238EAC-2AE2-4B8C-8093-3EB6EA722845Q37376557-D22C0EF0-DFC8-4C42-9C85-CE9E2CD0D569Q38115981-713B52F1-8E52-482D-B4C4-CDF1C70D940FQ38799356-0A15F11D-BA7A-418A-8C33-D8ECEED57361Q38831825-BF6FC1F8-3848-40EE-A40C-19D9FFA8D433Q38833728-227BE592-F537-4685-837D-77A0F7F16DFDQ38850703-F481F402-0994-4E18-A0FB-B23A9B023754Q39021847-1D48602D-47F0-4A4E-AB14-65727CEC6449Q39154600-CDBA5DBB-7A9E-460B-BAB5-8E55ADF9EA97Q39155863-A3B7F87C-27F8-440A-8439-167B1D3D6D66Q39825453-7817C3C6-5B50-4EDA-A580-B3E0FF452FD1Q40272685-CAB8FD1A-9071-4CB9-ABF0-EEC970CD6321Q41583623-08C8B7BE-A96F-4EDD-BBD8-CCDDC5BCD085Q43002836-03456542-FD60-45E9-94DF-AA954C034B58Q45254066-08FFC4F5-43DD-43A8-913F-B72B55AB429EQ47200008-08B5A6FB-3506-4F77-809C-9B74DE45D30AQ49774225-340203E9-6AC9-42C5-892B-2B57539F4FE0
P2860
Reduced antibody response to streptavidin through site-directed mutagenesis
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reduced antibody response to streptavidin through site-directed mutagenesis
@ast
Reduced antibody response to streptavidin through site-directed mutagenesis
@en
Reduced antibody response to streptavidin through site-directed mutagenesis
@nl
type
label
Reduced antibody response to streptavidin through site-directed mutagenesis
@ast
Reduced antibody response to streptavidin through site-directed mutagenesis
@en
Reduced antibody response to streptavidin through site-directed mutagenesis
@nl
prefLabel
Reduced antibody response to streptavidin through site-directed mutagenesis
@ast
Reduced antibody response to streptavidin through site-directed mutagenesis
@en
Reduced antibody response to streptavidin through site-directed mutagenesis
@nl
P2093
P2860
P3181
P356
P1433
P1476
Reduced antibody response to streptavidin through site-directed mutagenesis
@en
P2093
J M Jackson
J Sanderson
S S Graves
P2860
P304
P3181
P356
10.1110/PS.19901
P407
P577
2001-03-01T00:00:00Z